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Abstract  
Introduction: The purpose of this study was to examine the effect of payer 
status on indicators of the quality of diabetes care delivered in four health care 
systems that participated in a REACH Coalition’s efforts to eliminate health care 
disparities for African Americans with diabetes. 
Design and Methods: Secondary analyses of data from 899 health care records 
of people who received diabetes care were conducted to determine differences in 
quality of care by payer status. Extracted information included process 
information related to frequency of A1C, lipid, and kidney tests, foot 
examinations, and blood pressure measurements, as well as intermediate health 
outcomes for blood pressure control, A1C results, lipid results, and kidney tests.  
Multivariate logistic regression, which included variables that had a change >10% 
for any payer status (based on odds ratio), was used to predict the likelihood of a 
person with diabetes receiving a care measure and/or achieving desired health 
outcomes related to diabetes control.  
Results: There were no significant differences observed except: (1) LDL 
cholesterol control where Medicare enrollees and Medicaid recipients 
experienced poorer outcomes than those with commercial insurance (p = 0.04 for 
both); and (2) foot exams where Medicaid recipients received fewer annual 
exams than those with no insurance (p = 0.034). 
Conclusions: Payer status had little effect on quality of diabetes care among this 
population. Other influences not accounted for in this study apparently have a 
great impact on quality of care in these four health systems.  
Keywords: Diabetes, Health Insurance, Health care, Diabetes Outcomes, 
Quality Care 
The Effect of Payer Status on the Quality of Diabetes Care: Results from a 
REACH 2010 Project 
Diabetes mellitus (DM) is a growing public health epidemic. Approximately 23.6 
million Americans have diabetes, and this number will likely double by 2050.1 
Previous large studies2,3 have identified methods to prevent or delay 
development of diabetes and its complications. Several national organizations 
and federal agencies such as the Centers for Medicare and Medicaid (CMS), 
American Diabetes Association (ADA), and National Committee for Quality 
Assurance (NCQA), have focused on improving the quality of care for people 
living with diabetes4-7 and have identified and widely disseminated evidenced-
based guidelines for the management of diabetes. Current practices, however, 
remain suboptimal, and disparities in diabetes care are common.8-11 
REACH 2010: Charleston and Georgetown Diabetes Coalition (REACH) is a 
demonstration project funded by the Centers for Disease Control and Prevention. 
Formed in 1999 as a broad-based, community-driven coalition incorporating the 
principles of community-based participatory research, the coalition focuses on 
improving health for African Americans (AfA) living with diabetes in Charleston 
and Georgetown Counties. 
Literature Review and Background 
Many people with diabetes lack necessary resources for adequate health care. 
An estimated 47 million Americans are without health insurance costing the US 
public more than 130 billion dollars annually.12 Uninsured adults are greater than 
three times more likely to lack a regular source of health care resulting in poor 
continuity; thus, many have reported that the uninsured are far less likely to 
receive evidence based care. For example, uninsured persons with diabetes 
have been shown to receive significantly fewer preventive measures deemed 
essential for quality diabetes care by the ADA.12-17   
Health related outcomes are highly influenced by health care access and use, 
which have been shown to be greatest among those with any healthcare payer 
compared to those without any third party payer. The quality of health care is 
influenced by complicated payment systems, multiple payment types, and use of 
reimbursement as either incentives or disincentives.18-24 Based on the theoretical 
framework presented in his book “The theory of demand for health insurance”, 
John A. Nyman theorizes that consumers purchase health insurance so that they 
can purchase high-value care when they become ill. They pay a premium in 
exchange for health care when needed.  Private health insurance and Medicare 
Part B (covering 80% of customary costs of physician services, diabetes care, 
supplies and education) fall into the consumer purchased health insurance, while 
Medicaid falls into a government funded health insurance for specific groups of 
those unable to pay.  Those who have no private or government funded health 
insurance usually bare the full cost of their care when ill or free or sliding scale 
costs are based on the health care facility’s policies and abilities to provide 
care.25 
The effects of payer status have been shown to independently influence diabetes 
care and outcomes,14,24 but little research has been done to examine the effect 
that different payer types may have on diabetes care and outcomes. 
Furthermore, no studies were identified that included data for South Carolina, a 
state that has a disproportionate percentage of the population affected by 
diabetes.  
The purpose of this study was to examine the effect of payer status on indicators 
of the quality of diabetes care delivered in four health care systems (two federally 
qualified health centers, a primary care center in the community, and an 
academic medical center specialty clinic) that participated in REACH Charleston 
and Georgetown Diabetes Coalition (REACH) efforts to eliminate health care 
disparities for African Americans with diabetes. REACH is a demonstration 
project funded by the Centers for Disease Control and Prevention. Formed in 
1999 as a broad-based, community-driven coalition incorporating the principles 
of community-based participatory research, the coalition focuses on improving 
health for African Americans (AfA) living with diabetes in Charleston and 
Georgetown Counties.  
The null hypotheses of this study were: There are no differences in the quality of 
care for diabetes between/among: 
 Medicare enrollees compared to commercial insurance enrollees.  
 Medicaid recipients compared to commercial insurance enrollees.  
 Medicare enrollees and those with no insurance.  
 Medicaid recipients and those with no insurance.  
 Those with no insurance compared to commercial insurance enrollees.  
 Those with Medicaid compared to those with Medicare.  
Methods 
This quantitative, non-experimental study used a retrospective, cross-sectional 
secondary analysis of REACH health record audit data to assess the quality of 
care received by persons with diabetes in two counties in South Carolina during 
the years 2001 to 2003.  First, we present a brief overview of the methods for the 
collection of the original data, and then discuss the methods for this secondary 
analysis (current study design).  Both studies were approved by the Institutional 
Review Board for Human Research at the Medical University of South Carolina. 
The primary dependent variables to determine quality of care based on payer 
status were annual A1C and lipid testing, foot exams (≤1 or ≥2 per year), LDL-C 
value (≤100 mg/dl; >130 mg/dl), A1C value (>9.0%; ≤7.0%) blood pressure 
control (≤130/80 mm Hg), and microalbumin results (+ or -). The primary 
independent variables were Medicare, Medicaid, commercial insurance, and no 
third party payer.  Covariates identified through the literature review and previous 
REACH data analyses included age, race, gender, and clinic or health system 
site.  
Data Collection: Data were collected from a randomly selected list of all patients 
with diabetes served by four different health systems: two federally qualified 
health centers, a primary care center in the community, and an academic 
medical center specialty clinic. Inclusion criteria were: adult ≥18 years, diagnosis 
of diabetes prior to study year, ≥1 visit to health provider within study year. 
Exclusion criteria were: prisoner, documented pregnancy, non-community 
dwelling (ex. nursing home), or terminal illness (ex. hospice referral). Mitchell’s 
sample size calculator was used to determine the number of subjects needed 
from each clinical site. The total needed for each site was then divided into the 
total number of patients actively managed at each site, and random selection 
was made based on a table of random numbers. 
Data were entered into Microsoft Access via laptop computers using a REACH 
data collection instrument. Utilizing a 15 month collection timeframe allowed 
documentation of patient’s annual care and time for providers to document 
results of tests ordered throughout the previous year, and approximately three 
months into the following year (to allow for appointments slightly beyond the 12 
month period for annual tests). Data collection was completed by trained 
abstractors. A reviewer independently re-abstracted a randomly selected sample 
(10% of total from each site) of medical records and compared the data to initial 
abstraction and all differences were resolved by concensus; average interrater 
reliability on all categorical variables was high (96%) as assessed by the Kappa 
statistic.  
In this secondary analysis, data for the study were generated by the REACH data 
analyst from all de-identified patients’ records in the REACH database. The data 
set was electronically transferred into SPSS. No personal identifiers were 
attached to the data set. Data for years 2001, 2002, and 2003 were combined 
into one data set. Power calculations for this study used SPSS PowerSample 12. 
With a total of 899 subjects, this study could detect a difference of 6% with a 
power of 80% and α of 0.5.  
Variables: Variables used to measure quality of care in the settings included 
both using process measures (A1C testing, lipid testing, and number of foot 
examinations) and intermediate outcomes measures (A1C results, LDL-C results, 
kidney test results [microalbumin], and last recorded BP results). These 
indicators of quality were chosen based on definitions provided by the Diabetes 
Quality Improvement Project (DQIP),4 4 Health Effectiveness Data and 
Information Set (HEDIS),26 the Foundation for Accountability, and accepted 
standards of diabetes care from the ADA. Data from both the process and the 
intermediate outcome measures were analyzed first as a composite score for all 
subjects and then stratified by payer type for each quality measure. The data 
were then further disaggregated by demographic variables (age, race, gender, 
and clinic site) where categories provided sufficient sample size. 
Data Analysis: Continuous demographic data (age) were analyzed using 
ANOVA for differences between groups. Data analyses on categorical 
demographics (race, sex, clinic site), as well as the proportion of patients 
receiving diabetes care measures (diabetes related testing and results), were 
completed using the χ2 statistical test. To assess if payer status was 
independently associated with the likelihood of receiving quality diabetes care for 
each indicator collectively and individually, multivariate logistic regression 
analysis was performed with a focus on the variable for payer type. 
Absolute percentages and proportions for each measure are reported as the 
percent of patients receiving recommended care. Absolute measures for each 
independent health care payer type and by health care facility are also reported. 
Disaggregating by payer type, gender, race, and age where appropriate was 
completed for each variable. Appropriateness for inclusion of all demographic 
variables (with exception of continuous data, i.e. age) was completed using 
stratification and non-stratification methods. An odds ratio (OR) or the probability 
of occurrence over the probability of non-occurrence for obtaining selected health 
care services or outcomes was provided for each measure of quality for each 
individual payer source.  The OR represented the probability of an individual 
receiving quality diabetes care. 
Potential confounders were evaluated to determine which covariates were to be 
included in these analyses. Possible covariates identified in the literature 
included race, gender, age, payer source, income, geographical location of care, 
comorbid conditions, and clinic setting.26,27 Variables whose addition changed the 
OR for diabetes care >10% were included in the models used to test the 
hypotheses of this study.29 
Statistical Analyses  
Multivariate logistic regression models were completed for each of the five 
hypotheses in exactly the same manner; only the payer focus in each of the 
regression models changed to reflect comparisons between groups by payer 
status. 
The statistical analyses of the data were examined first by demographics and 
process measures and intermediate outcomes by payer status. Covariates were 
then determined by literature search and knowledge of the most frequent 
comorbidities within this population. After inclusion of the selected covariates, 
multivariate logistic regression models were completed to determine the 
likelihood (OR) of an individual receiving process measures and achieving the 
desired intermediate outcomes related to diabetes. The likelihood of receiving a 
process of care measure or attaining the desired intermediate outcome was 
represented by an OR of the dependent variable (process measures and 
intermediate outcomes) given the influence of the independent variable and the 
effects of the selected covariates.  
Results 
There were a total of 899 records included in the study, representing about 34% 
Medicare, 32% with no insurance recorded, 24% with commercial insurance and 
10% with Medicaid. Approximately 62% were female and 27% were males, and 
11% did not identify gender (table 1).  
Results of the multivariate logistic regression model to determine the OR for 
receiving each of the quality of care measures are displayed in table 2. The first 
number represents the adjusted OR for receiving measures of care or obtaining 
recommended levels of test results. The adjusted OR is followed by the 95% CI 
and the final column is the p-value for significance.  
Null Hypothesis 1: For the intermediate outcome measures, Medicare enrollees 
were 2.0 time more likely to have an LDL-C >130 mg/dl than those with 
commercial insurance (p=0.04) (table 2). There were no significant differences in 
the process measures for quality of diabetes care for Medicare enrollees when 
compared to those with commercial insurance.    
Null Hypothesis 2: For outcome measures, Medicaid enrollees were 1.8 times 
more likely to have an LDL-C > 130 mg/dl than those with commercial insurance 
(p=0.04) (table 2). There were no significant differences in the process of care 
measures for quality diabetes care for Medicaid recipients when compared to 
those with commercial insurance.  
Null Hypothesis 3: There are no differences in either process of care measures 
or outcome measure when assessing the quality of diabetes care for Medicare 
enrollees when compared to those with no insurance (table 2).  
Null Hypothesis 4: For process measures used to assess the quality of diabetes 
care, those with no insurance were 1.6 times more likely to have the 
recommended ≥2 annual foot examinations than Medicaid enrollees (p=0.03) 
(table 2).There are no differences found among process of care measures for the 
quality of diabetes care for Medicaid recipients when compared to those with no 
insurance.  
Null Hypothesis 5: There were no differences found in either process of care 
measures or outcome measures used to assess the quality of diabetes care 
among those with no insurance when compared to those with commercial 
insurance (table 2).  
Null Hypothesis 6: There were no differences in process of care or outcome 
measure used in this study to assess the quality of diabetes care for Medicaid 
recipients when compared to Medicare enrollees (table 2).  
Summary of findings:  When accounting for race, gender, age, type of 
diabetes, type of clinic where care was received, geography, and co-morbidities 
of care, this study found few differences in the quality of diabetes care based on 
payer status. Among the process of care measures, when compared to those 
with commercial insurance or those with no insurance provider, Medicaid 
enrollees were significantly less likely to receive ≥2 foot examinations annually (p 
= 0.03). For outcome measures, Medicare (p = 0.04) and Medicaid (p = 0.04) 
enrollees were more than twice as likely to have an LDL-C level of >130 mg/dl 
when compared to those with commercial or no insurance. 
 
Discussion 
The findings of this study are not consistent with other published findings that 
found payer status had greater influences on the quality of diabetes care and 
outcomes.14-17,28,30 Among the subjects in this study, regardless of payer status, 
those having fewer apparent resources were found to receive equal quality of 
care. Care was taken to account for potential extraneous variables in each of the 
regression models. Thus, it is plausible that additional avenues of support other 
than payer status exist for the persons in this study. 
Applying Nyman’s theory of demand for health insurance,25 private insurance and 
Medicare Part B were purchased by individuals to access high-value care and 
could assist the individuals in accessing higher quality care for diabetes when 
needed.  However, the government sponsored Medicaid and the government 
supported care in state supported academic institutions (academic health 
centers) and the HRSA supported community health centers may also have 
contributed to quality care.  And when care guidelines are established by national 
organizations and widely promulgated at local, state and national levels, we 
theorize quality of diabetes care improved for all.25 
Although the findings of significant differences by payer were few (Medicaid 
enrollees less likely to receive foot exams and Medicare and Medicaid enrollees 
less likely to have controlled LDL-C), they are serious. People with diabetes 
experience higher rates of cardiovascular events such as strokes, heart failure, 
vascular disease and myocardial infarctions and as many as 80% of persons with 
diabetes will die as a result of coronary and vascular diseases.11 Even small 
improvements in A1C and lipid controls can significantly reduce these 
morbidities.  
This study was designed to detect differences in lipid control among different 
payer sources through carefully constructed multiple regression modeling. 
However, there are some potential explanations not accounted for in the 
regression models utilized such as adherence to the providers’ 
recommendations, diet, and exercise. Although REACH does not have a direct 
measure of adherence to medical therapy, 70% of all Medicare enrollees in this 
study had at least one annual lipid test ordered and completed. This is well 
above the national averages of 31-56%.  
Exercise and diet are known to improve lipid control. Within the population for 
this study, Medicaid recipients and Medicare enrollees were significantly older 
(average 8 years) than those with commercial insurance. Adults with Medicaid 
self-reported fewer days of physical activity than other groups. Information on 
physical activity, however, was limited in the REACH database. Although 
providers often mentioned self-reported activity, there were little data regarding 
the intensity of such activities. Although infrequently recorded in the patient 
records in broad terms, specific information on diet therapy was not available for 
this study.   
One major difference identified between this and previous studies, is we 
collected data from health centers and clinical sites where REACH is actively 
engaged in improving care for persons with diabetes. We postulate that the 
impact of REACH within each of these sites may have influenced the quality 
diabetes care provided to all individuals regardless of the payment structure. 
Based on earlier reports of analyses of the data,31 significant improvements in 
reducing racial disparities have occurred for both the insured and uninsured. 
However, it should be noted that initial data collected “insurance” or “no 
insurance” but did not collect type of insurance until 2001.   
Since 1999, REACH, a nurse-led project, and its community-based coalition 
partners, have been involved with each of the four affiliated healthcare sites, and 
designed and implemented, in conjunction with each site, interventions aimed at 
reducing disparities in diabetes care and outcomes. For example, over 150 
nurses were trained to conduct diabetes related foot examinations at the time of 
visit. This frees the provider to focus on other issues while assuring that each 
patient received the recommended foot care.  
REACH expands its efforts beyond the structure of the site of care by making 
patients partners in their healthcare. Examples of patient directed quality of care 
issues include “Gold Cards” which are cards patients carry to document 
individual goals and outcomes as well as providing information on recommended 
frequency of tests; on-site lay led diabetes classes; and courses on 
client/provider communications in an effort to improve overall self-management 
skills and knowledge among those with diabetes.  
Conclusions and next steps 
In summary, the conclusions of this study are not consistent with the findings of 
other published studies. Among this population, few differences in the quality of 
diabetes care by payer status were identified. It is likely that among this 
population, factors other than payer status had a greater influence on the quality 
of diabetes care than payer status. Whether these factors include provider 
practice habits, patient compliance, or self-management skills cannot be 
determined from this study.  
Repetition of this study in similar populations with a larger sample size would 
help to determine if current quality of care by payer differs in other communities, 
as had previously been reported in earlier studies in the literature. Additionally, 
testing each specific REACH intervention in other populations and states is 
recommended to determine efficacy and effectiveness for improving care among 
other populations. Our next steps are to explore further improvements in diabetes 
control as evidenced by improved A1C, blood pressure and lipid outcomes. 
Studies are also needed to evaluate the effect of provider teams designed to 
provide quality medical care based on ADA guidelines, as well as comprehensive 
disease management education to both the patient and the family caregivers.  
Nurses are a crucial, but under-used component of this type team approach, 
especially in primary care settings where most diabetes care takes place. 
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Table 1  
Sample Size by Race, Gender, and Payer Status for Chart Audit Data of  
People with Diabetes seen in Health Systems Participating in REACH  
Charleston and Georgetown Diabetes Coalition (2001-2003) 
  
Sample by 
Race and 
Gender 
Payer Status 
Medicare 
# 
(%) 
Medicaid 
# 
(%) 
None 
# 
(%) 
Commercial 
Insurance 
# 
(%) 
Total 
# 
(%) 
African 
American 
female 
181  
(77) 
66  
(85) 
134  
(72) 
72  
(81) 
453 
(50.4) 
African 
American 
male 
55  
(23) 
12  
(15) 
52  
(28) 
17  
(19) 
136 
(15.1) 
Non-
Hispanic 
White 
female 
27  
(55) 
4  
(67) 
20  
(59) 
58  
(48) 
109 
(12.1) 
Non-
Hispanic 
White male 
22  
(45) 
2  
(33) 
14  
(41) 
64  
(52) 
102 
(11.3) 
Race  and 
Gender not 
documented  
18  
(6) 
3  
(3) 
70  
(24) 
8  
(4) 
99  
(11.0) 
Total  303  
(34) 
87  
(10) 
290  
(32) 
219  
(24) 
899 
(100)a 
 
a Total is actually 99.9% but rounded to 100%    
Table 2 
Comparison of Process and Outcomes Measures Disaggregated by Payer Status 
Process Measures 
Payer Status Medicare vs. 
Comm. 
Medicaid vs. 
Comm. 
Medicare vs. 
uninsured 
Uninsured vs. 
Medicaid 
Uninsured vs. 
Comm. 
Medicaid vs. 
Medicare 
Statistical 
Measures 
OR CI Sig. OR CI Sig. OR CI Sig. OR CI Sig. OR CI Sig. OR CI Sig. 
A1C test ≥ 1 
annually 
1.00 0.40,2.53 0.98 1.05 0.37, 
2.97 
0.92 0.93 0.7, 
11.79 
0.96 1.3 0.6, 
2.8 
0.51 0.9 0.28, 
1.64 
0.39 0.9 0.4,1.8 0.98 
A1C  test ≥ 2 
annually 
0.99 0.53,1.9 0.99 1.4 0.71, 
3.1 
0.29 0.9 0.53, 
1.6 
0.80 1.4 0.7, 
2.7 
0.36 1.1 0.6, 
2.0 
0.8 1.2 0.5,1.2 0.51 
AIC test ≥ 4 
annually 
0.92 0.78,4.9 0.15 1.14 0.37, 
0.54 
0.81 0.96 0.4, 2.3 0.93 1.3 0.6, 
2.8 
0.50 1.1 0.43, 
2.7 
0.87 1.1 0.5,1.8 0.58 
Lipid test ≥ 1 
annually 
0.81 0.31,2.1 0.81 1.18 0.38, 
3.62 
0.77 0.79 0.3,1.99 0.62 0.66 0.3, 
1.4 
0.29 1.3 0.51, 
3.2 
0.59 1.1 0.4,2.2 0.90 
Foot exam ≥ 
2 annually 
0.50 0.22,1.17 0.11 2.02 0.74, 
5.54 
0.17 0.94 0.4, 2.0 0.87 1.62 1.0, 
2.7 
0.03c 1.0 0.47, 
2.45 
0.86 0.8 0.4,1.6 0.60 
B/P check ≥ 1 
annually 
0.39 0.09,1.7 0.21 0.41 0.08, 
2.0 
0.27 0.63 0.1, 3.9 0.10 0.24 0.04, 
1.3 
0.10 1.5 0.25, 
9.97 
0.62 0.1 0.03,1.1 0.06 
Microalbumin 
test ≥ 1 
annually 
1.45 0.7,2.97 0.31 0.86 0.36, 
2.1 
0.75 0.84 0.4, 1.7 0.62 1.2 0.64, 
2.3 
0.55 1.2 0.6, 
2.4 
0.62 1.1 0.5,1.9 0.87 
Outcome Measures  
Payer Status Medicare vs. 
Comm. 
Medicaid vs. 
Comm. 
Medicare vs. 
uninsured 
Uninsured vs. 
Medicaid 
Uninsured vs. 
Comm. 
Medicaid vs. 
Medicare 
Statistical 
Measures 
OR CI  Sig. OR CI Sig. OR CI Sig. OR CI Sig. OR CI Sig. OR CI Sig. 
A1C ≤ 7.0% 0.68 0.37,1.2 0.22 1.3 0.6, 
2.9 
0.45 1.5 0.65, 
3.4 
0.34 0.64 0.37, 
1.1 
0.11 1.0 0.5, 
1.9 
0.84 0.2 0.1,1.5 0.46 
A1C > 9.0% 1.1 0.41,2.95 0.84 0.674 0.22, 
2.06 
0.48 0.70 0.3, 
1.8 
0.46 1.0 0.5, 
2.4 
0.83 1.6 0.6, 
4.2 
0.33 0.9 0.5, 1.8 0.98 
LDL-C ≤ 100 
mg/dl 
0.61 0.4,1.0 0.69 0.48 0.2, 
0.9 
0.37  0.8 0.4, 
1.8 
0.60 0.9 0.5, 
1.9 
0.93 0.7 0.42, 
1.2 
0.25 0.8 0.4,1.6 0.56 
LDL-C > 130 
mg/dl 
2.0 0.66,4.47 0.04c 1.8 0.7, 
4.8 
0.04c 0.56 0.2, 
1.5 
0.23 1.3 0.56, 
3.0 
0.32 1.7 0.66, 
4.5 
0.26 1.0 0.4,2.3 0.91 
BP > 130/80 
mm Hg 
0.69 0.38,1.26 0.22 1.06 0.51, 
2.2 
0.87 1.1 0.6, 
2.0 
0.72 0.77 0.45, 
1.3 
0.33 0.9 0.5, 
1.6 
0.72 0.8 0.2,2.9 0.75 
Nephropathy 1.4 0.37,5.4 0.61 0.88 1.7, 
4.5 
0.88 0.45 0.09, 
2.1 
0.31 0.64 0.14, 
3.0 
0.57 2.2 0.5, 
10.2 
0.31 0.9 0.2,3.4 0.93 
 Comm. = Commercial Insurance 
OR = Odds Ratio 
CI = Confidence Interval (95%) 
Significance at α 0.05  
  
 
